.Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law.No. 10, Vol. 2. Washington, DC: US Government Printing Office; 1949:181–182
World Medical Organization, 1996, BMJ., 1996, 1448
Freedman B, 1987, N Engl J Med., 317, 141, 10.1056/NEJM198707163170304
Brandt AM, 1978, Hastings Cent Rep., 8, 21, 10.2307/3561468
. Code of Federal Regulations—The Common Rule: Protection of Human Subjects. In: Services DoHaH, ed. Vol 45. 2009
Lansimies-Antikainen H, 2010, Scand J Caring Sci., 24, 56, 10.1111/j.1471-6712.2008.00684.x
Ridpath JR, 2009, Am J Health Promot., 23, 371, 10.4278/ajhp.080613-CIT-94
Gravetter FJ, 2009, Research Methods for the Behavioral Sciences., 3
Dickert N, 1999, N Engl J Med., 341, 198, 10.1056/NEJM199907153410312
Prentice RL, 1989, Stat Med., 8, 431, 10.1002/sim.4780080407
Chobanian AV, 2003, Hypertension., 42, 1206, 10.1161/01.HYP.0000107251.49515.c2
10.7326/0003-4819-125-7-199610010-00011
Temple R, 1999, JAMA., 282, 790, 10.1001/jama.282.8.790
10.1056/NEJM199103213241201
A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease, 1991, N Engl J Med., 324, 509, 10.1056/NEJM199102213240801
Buyse M, 2010, Nat Rev Clin Oncol., 7, 309, 10.1038/nrclinonc.2010.43
International Conference on Harmonisation, 1994, Good clinical practice guidelines for essential documents for the conduct of a clinical trial
Joffe S, 2001, Lancet., 358, 1772, 10.1016/S0140-6736(01)06805-2
Cahana A, 2007, J Anesth., 21, 102, 10.1007/s00540-006-0440-7
Foddy B, 2009, Am J Bioeth., 9, 4, 10.1080/15265160903318350
Wilcox CM, 2008, Gastrointest Endosc., 67, 123, 10.1016/j.gie.2007.09.003
Levine RJ, 1999, N Engl J Med., 341, 531, 10.1056/NEJM199908123410713
Vastag B, 2000, JAMA., 284, 2983, 10.1001/jama.284.23.2983
Walker E, 2011, J Gen Intern Med., 26, 192, 10.1007/s11606-010-1513-8
Fleming TR, 2008, Stat Med., 27, 317, 10.1002/sim.2855
Doll R, 1992, BMJ., 305, 1521, 10.1136/bmj.305.6868.1521
Hill AB, 1963, Br Med J., 1, 1043, 10.1136/bmj.1.5337.1043
Scott NW, 2002, Control Clin Trials., 23, 662, 10.1016/S0197-2456(02)00242-8
Tsiatis A, 1990, J Acquir Immune Defic Syndr., 3, S120
Moher D, 2001, JAMA., 285, 1987, 10.1001/jama.285.15.1987
Schulz KF, 2010, BMJ., 340, c332, 10.1136/bmj.c332
Fontanarosa PB, 2004, JAMA., 292, 2647, 10.1001/jama.292.21.2647
Bakke OM, 1995, Clin Pharmacol Ther., 58, 108, 10.1016/0009-9236(95)90078-0
Strom BL, 2004, JAMA., 292, 2643, 10.1001/jama.292.21.2643
2010, AERS patient outcomes by year
Maro JC, 2009, Ann Intern Med., 151, 341, 10.7326/0003-4819-151-5-200909010-00139
Berlin JA, 1999, JAMA., 281, 830, 10.1001/jama.281.9.830
Hennekens CH, 2009, JAMA., 302, 2361, 10.1001/jama.2009.1756
Mello MM, 2003, Ann Intern Med., 139, 40, 10.7326/0003-4819-139-1-200307010-00011
Steinbrook R, 2002, N Engl J Med., 346, 716, 10.1056/NEJM200202283460924
Ellenberg S, 2002, Data Monitoring Committees in Clinical Trials: A Practical Perspective, 10.1002/0470854162
Guidance for Industry, 1996, E6. Good clinical practice—consolidated guidance
Issa AM, 2007, Curr Drug Saf., 2, 177, 10.2174/157488607781668855
